Literature DB >> 15513871

Inhibitory effects of TSG-6 Link module on leukocyte-endothelial cell interactions in vitro and in vivo.

Thong V Cao1, Mylinh La, Stephen J Getting, Anthony J Day, Mauro Perretti.   

Abstract

OBJECTIVE: The authors investigated whether the anti-inflammatory protein tumor necrosis factor (TNF)-stimulated gene-6 (TSG-6) and its Link module (Link_TSG6) could affect the complex multistep process of leukocyte/endothelial cell (EC) interaction.
METHODS: Mouse mesenteries were inflamed with interleukin (IL)-1beta and the extent of leukocyte rolling, adhesion, and emigration was determined after 2 h. Link_TSG6 and a single-point mutant (termed K13E) were given intraperitoneally together with the cytokine. Human neutrophil chemotaxis and transmigration were determined in vitro in response to IL-8 and/or TNF-alpha. TSG-6, Link_TSG6, and K13E were added to the leukocytes or the EC monolayers.
RESULTS: Co-injection of Link_TSG6 with IL-1beta selectively inhibited cell flux, adhesion, and emigration as analyzed in mesenteric postcapillary venules. The fewer cells that rolled in the animals treated with Link_TSG6 displayed a velocity similar to that measured in vehicle-treated mice. In vitro, Link_TSG6 did not affect neutrophil chemotaxis or EC activation but did inhibit neutrophil transmigration across EC monolayers. The latter effect was shared by full-length TSG-6 and observed equally in response to IL-8 or TNF-alpha.
CONCLUSIONS: These data restrict the site of action for at least some of the anti-inflammatory effects ascribed to TSG-6/Link_TSG6 to the microenvironment of the extravasating leukocyte.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15513871     DOI: 10.1080/10739680490503438

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  26 in total

1.  TSG-6 protein expression in the pancreatic islets of NOD mice.

Authors:  M Kvezereli; S A Michie; T Yu; R J Creusot; M J Fontaine
Journal:  J Mol Histol       Date:  2008-11-01       Impact factor: 2.611

2.  TSG-6 potentiates the antitissue kallikrein activity of inter-alpha-inhibitor through bikunin release.

Authors:  Rosanna Forteza; Susana M Casalino-Matsuda; Maria Elena Monzon; Erik Fries; Marilyn S Rugg; Caroline M Milner; Anthony J Day
Journal:  Am J Respir Cell Mol Biol       Date:  2006-07-27       Impact factor: 6.914

3.  Cutaneous Wounds in Mice Lacking TSG-6 Exhibit Delayed Closure and an Abnormal Inflammatory Response.

Authors:  Sajina Shakya; Judith A Mack; Minou Alipour; Edward V Maytin
Journal:  J Invest Dermatol       Date:  2020-05-15       Impact factor: 8.551

4.  Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury.

Authors:  Joo Youn Oh; Gavin W Roddy; Hosoon Choi; Ryang Hwa Lee; Joni H Ylöstalo; Robert H Rosa; Darwin J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-13       Impact factor: 11.205

5.  Administration of TSG-6 improves memory after traumatic brain injury in mice.

Authors:  Jun Watanabe; Ashok K Shetty; Bharathi Hattiangady; Dong-Ki Kim; Jessica E Foraker; Hidetaka Nishida; Darwin J Prockop
Journal:  Neurobiol Dis       Date:  2013-07-11       Impact factor: 5.996

6.  Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis.

Authors:  Carine Blanchard; Ning Wang; Keith F Stringer; Anil Mishra; Patricia C Fulkerson; J Pablo Abonia; Sean C Jameson; Cassie Kirby; Michael R Konikoff; Margaret H Collins; Mitchell B Cohen; Rachel Akers; Simon P Hogan; Amal H Assa'ad; Philip E Putnam; Bruce J Aronow; Marc E Rothenberg
Journal:  J Clin Invest       Date:  2006-02       Impact factor: 14.808

7.  TSG-6 protein is crucial for the development of pulmonary hyaluronan deposition, eosinophilia, and airway hyperresponsiveness in a murine model of asthma.

Authors:  Shadi Swaidani; Georgiana Cheng; Mark E Lauer; Manisha Sharma; Katalin Mikecz; Vincent C Hascall; Mark A Aronica
Journal:  J Biol Chem       Date:  2012-11-01       Impact factor: 5.157

8.  Phase-directed therapy: TSG-6 targeted to early inflammation improves bleomycin-injured lungs.

Authors:  Andrea M Foskett; Nikolay Bazhanov; Xinyu Ti; April Tiblow; Thomas J Bartosh; Darwin J Prockop
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-15       Impact factor: 5.464

9.  The N-terminal module of thrombospondin-1 interacts with the link domain of TSG-6 and enhances its covalent association with the heavy chains of inter-alpha-trypsin inhibitor.

Authors:  Svetlana A Kuznetsova; Anthony J Day; David J Mahoney; Marilyn S Rugg; Deane F Mosher; David D Roberts
Journal:  J Biol Chem       Date:  2005-07-08       Impact factor: 5.157

10.  TSG-6 inhibits neutrophil migration via direct interaction with the chemokine CXCL8.

Authors:  Douglas P Dyer; Jennifer M Thomson; Aurelie Hermant; Thomas A Jowitt; Tracy M Handel; Amanda E I Proudfoot; Anthony J Day; Caroline M Milner
Journal:  J Immunol       Date:  2014-02-05       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.